Brief: Checkpoint Therapeutics Says Got Letter From Nasdaq Confirming It Was Not In Compliance With Board Independence Rule
02/02/2024 22:27
Feb 2 (Reuters) - Checkpoint Therapeutics Inc CKPT.O :
* CHECKPOINT THERAPEUTICS - GOT LETTER FROM NASDAQ
CONFIRMING
THAT CO WAS NO LONGER IN COMPLIANCE WITH BOARD INDEPENDENCE RULE
Source text for Eikon: ID:n0001104659-24-010161
Further company coverage: CKPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Checkpoint Therapeutics
See all newsCheckpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Street View -India's Sun Pharma buying Checkpoint boosts its specialty portfolio, analysts say